In fact, a recent study reported the crucial role of CD8+ T cells in contributing to the survival of patients with COVID-19 and hematologic cancer, suggesting that CD8 T cells play a key role in limiting SARS-CoV-2, even in the absence of humoral immunity [22]. Here, CD8A is linked to hematopoietic and lymphoid cell neoplasm.